Prognostic significance of tumor budding in gastrointestinal tumors

References

• Prall F. Tumour budding in colorectal carcinoma. Histopathology50(1), 151–162 (2007).
   PubMedGoogle Scholar
• Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget1(7), 651–661 (2010).
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial–mesenchymal transition. J. Clin. Invest.119(6), 1420–1428 (2009).
   PubMed Web of Science ®Google Scholar
• Brabletz T, Hlubek F, Spaderna S et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and and β-catenin. Cells Tiss. Organs179(1–2), 56–65 (2005).
   PubMed Web of Science ®Google Scholar
• Märkl B, Renk I, Oruzio DV et al. Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer. J. Surg. Oncol.102(3), 235–241 (2010).
   PubMedGoogle Scholar
• Jass JR, Barker M, Fraser L et al.APC mutation and tumour budding in colorectal cancer. J. Clin. Pathol.56(1), 69–73 (2003).
   PubMed Web of Science ®Google Scholar
• Pusiol T, Piscioli F, Zorzi MG, Morichetti D. Accurate and reproducible definition of tumor budding as prognostic marker of colon cancer. Dis. Colon. Rectum53(11), 1576; author reply 1576 (2010).
   PubMedGoogle Scholar
• Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer63(3), 539–543 (1989).
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Yokoo T, Ishii T. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer112(4), 924–933 (2008).
   PubMed Web of Science ®Google Scholar
• Ono M, Sakamoto M, Ino Y et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer78(6), 1179–1186 (1996).
   PubMed Web of Science ®Google Scholar
• Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology40(2), 127–132 (2002).
   PubMed Web of Science ®Google Scholar
• Karamitopoulou E, Lugli A, Panayiotides I et al. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology57(2), 233–243 (2010).
   PubMedGoogle Scholar
• Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology47(1), 17–24 (2005).
   PubMed Web of Science ®Google Scholar
• Lugli A, Karamitopoulou E, Panayiotides I et al. CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer. Br. J. Cancer101(8), 1382–1392 (2009).
   PubMed Web of Science ®Google Scholar
• Ohtsuki K, Koyama F, Tamura T et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res.28(3B), 1831–1836 (2008).
   PubMed Web of Science ®Google Scholar
• Shinto E, Mochizuki H, Ueno H, Matsubara O, Jass JR. A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology47(1), 25–31 (2005).
   PubMed Web of Science ®Google Scholar
• Shinto E, Jass JR, Tsuda H et al. Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis. Colon Rectum49(9), 1422–1430 (2006).
   PubMed Web of Science ®Google Scholar
• Brown M, Sillah K, Griffiths EA et al. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology56(7), 893–899 (2010).
   PubMed Web of Science ®Google Scholar
• Koike M, Kodera Y, Itoh Y et al. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann. Surg. Oncol.15(7), 1977–1982 (2008).
   PubMed Web of Science ®Google Scholar
• Miyata H, Yoshioka A, Yamasaki M et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer115(14), 3324–3334 (2009).
   PubMed Web of Science ®Google Scholar
• Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis. Esophagus17(4), 333–337 (2004).
   PubMed Web of Science ®Google Scholar
• Gabbert H, Wagner R, Moll R, Gerharz CD. Tumor dedifferentiation: an important step in tumor invasion. Clin. Exp. Metastasis3(4), 257–279 (1985).
   PubMedGoogle Scholar
• Gabbert HE, Meier S, Gerharz CD, Hommel G. Tumor-cell dissociation at the invasion front: a new prognostic parameter in gastric cancer patients. Int. J. Cancer50(2), 202–207 (1992).
   PubMedGoogle Scholar
• Ohike N, Coban I, Kim GE et al. Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am. J. Surg. Pathol.34(10), 1417–1424 (2010).
   PubMed Web of Science ®Google Scholar
• Zlobec I, Molinari F, Martin V et al. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J. Gastroenterol.16(38), 4823–4831 (2010).
   PubMedGoogle Scholar
• Matsuda T, Gotoda T, Saito Y, Nakajima T, Conio M. Our perspective on endoscopic resection for colorectal neoplasms. Gastroenterol. Clin. Biol.34(6–7), 367–370 (2010).
   PubMedGoogle Scholar
• Elmas N, Killi RM, Sever A. Colorectal carcinoma: radiological diagnosis and staging. Eur. J. Radiol.42(3), 206–223 (2002).
   PubMedGoogle Scholar
• Gollub M. Update on colorectal cancer imaging. Radiol. Clin. North Am.45(1), 85–118 (2007).
   PubMedGoogle Scholar
• Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis. Colon Rectum48(8), 1588–1596 (2005).
   PubMedGoogle Scholar
• Ueno H, Mochizuki H, Hashiguchi Y et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology127(2), 385–394 (2004).
   PubMed Web of Science ®Google Scholar
• Yasuda K, Inomata M, Shiromizu A, Shiraishi N, Higashi H, Kitano S. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis. Colon Rectum50(9), 1370–1376 (2007).
   PubMed Web of Science ®Google Scholar
• Okabe S, Shia J, Nash G et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J. Gastrointest. Surg.8(8), 1032–1039; discussion 1039–1040 (2004).
   PubMedGoogle Scholar
• Hase K, Shatney CH, Mochizuki H et al. Long-term results of curative resection of ‘minimally invasive’ colorectal cancer. Dis. Colon Rectum38(1), 19–26 (1995).
   PubMedGoogle Scholar
• Homma Y, Hamano T, Otsuki Y, Shimizu S, Kobayashi H, Kobayashi Y. Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers. J. Surg. Oncol.102(3), 230–234 (2010).
   PubMed Web of Science ®Google Scholar
• Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J. Gastroenterol. Hepatol.21(7), 1115–1121 (2006).
   PubMed Web of Science ®Google Scholar
• Sohn DK, Chang HJ, Park JW et al. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J. Clin. Pathol.60(8), 912–915 (2006).
   PubMedGoogle Scholar
• Suzuki A, Togashi K, Nokubi M et al. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am. J. Surg. Pathol.33(11), 1601–1607 (2009).
   PubMedGoogle Scholar
• Tateishi Y, Nakanishi Y, Taniguchi H, Shimoda T, Umemura S. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod. Pathol.23(8), 1068–1072 (2010).
   PubMed Web of Science ®Google Scholar
• Ueno H, Price AB, Wilkinson KH, Jass JR, Mochizuki H, Talbot IC. A new prognostic staging system for rectal cancer. Ann. Surg.240(5), 832–839 (2004).
   PubMedGoogle Scholar
• Wang HS, Liang WY, Lin TC et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis. Colon Rectum48(6), 1182–1192 (2005).
   PubMedGoogle Scholar
• Yamauchi H, Togashi K, Kawamura YJ et al. Pathological predictors for lymph node metastasis in T1 colorectal cancer. Surg. Today38(10), 905–910 (2008).
   PubMedGoogle Scholar
• Schmiegel W, Reinacher-Schick A, Arnold D et al. Update S3-guideline ‘colorectal cancer’ 2008. Z. Gastroenterol.46(8), 799–840 (2008).
   PubMedGoogle Scholar
• Quirke P, Risio M, Lambert R, Karsa L, Vieth M. Quality assurance in pathology in colorectal cancer screening and diagnosis – European recommendations. Virchows Archiv.458(1), 1–19 (2010).
   Google Scholar
• Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin. Cancer Res.14(1), 143–148 (2008).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mitomi H, Kikuchi S, Ohtani Y, Sato K. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology52(65), 1432–1435 (2005).
   PubMed Web of Science ®Google Scholar
• Ueno H, Mochizuki H, Hashiguchi Y, Hatsuse K, Fujimoto H, Hase K. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br. J. Surg.91(3), 327–333 (2004).
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl Cancer Inst.96(19), 1420–1425 (2004).
   PubMed Web of Science ®Google Scholar
• Investigators IB. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators. J. Clin. Oncol.17(5), 1356–1363 (1999).
   PubMedGoogle Scholar
• Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J. Clin. Oncol.22(10), 1797–1806 (2004).
   PubMed Web of Science ®Google Scholar
• Losi L, Ponti G, Gregorio CD et al. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol. Res. Pract.202(9), 663–670 (2006).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mitomi H, Kanazawa H, Ohkura Y, Watanabe M. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis. Colon Rectum51(5), 568–572 (2008).
   PubMed Web of Science ®Google Scholar
• Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis. Colon Rectum46(8), 1054–1059 (2003).
   PubMed Web of Science ®Google Scholar
• Wang LM, Kevans D, Mulcahy H et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am. J. Surg. Pathol.33(1), 134–141 (2009).
   PubMed Web of Science ®Google Scholar
• Okuyama T, Nakamura T, Yamaguchi M. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis. Colon Rectum46(10), 1400–1406 (2003).
   PubMed Web of Science ®Google Scholar
• Choi HJ, Park KJ, Shin JS, Roh MS, Kwon HC, Lee HS. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int. J. Colorectal. Dis.22(8), 863–868 (2007).
   PubMedGoogle Scholar
• Ha SS, Choi HJ, Park KJ et al. Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma. Cancer Res. Treat.37(3), 177–182 (2005).
   PubMedGoogle Scholar
• Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor ‘budding’ in patients with colorectal cancer. Dis. Colon Rectum36(7), 627–635 (1993).
   PubMed Web of Science ®Google Scholar
• Kanazawa H, Mitomi H, Nishiyama Y et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis.10(1), 41–47 (2008).
   PubMedGoogle Scholar
• Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis. Colon Rectum45(5), 628–634 (2002).
   PubMed Web of Science ®Google Scholar
• Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J. Surg. Oncol.83(1), 42–47 (2003).
   PubMedGoogle Scholar
• Park KJ, Choi HJ, Roh MS, Kwon HC, Kim C. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis. Colon Rectum48(8), 1597–1602 (2005).
   PubMed Web of Science ®Google Scholar
• Zlobec I, Lugli A. Prognostic and predictive factors in colorectal cancer. J. Clin. Pathol.61(5), 561–569 (2008).
   PubMed Web of Science ®Google Scholar
• Hörkko T, Klintrup K, Makinen J et al. Budding invasive margin and prognosis in colorectal cancer – no direct association with β-catenin expression. Eur. J. Cancer42(7), 964–971 (2006).
   PubMed Web of Science ®Google Scholar
• Sy J, Fung CLS, Dent OF, Chapuis PH, Bokey L, Chan C. Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis. Colon Rectum53(3), 301–307 (2010).
   PubMedGoogle Scholar
• Spaderna S, Schmalhofer O, Hlubek F et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology131(3), 830–840 (2006).
   PubMed Web of Science ®Google Scholar